{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Ultralife Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics
Ultralife Corp., a microcap in the Electronics & Appliances sector, has adjusted its valuation, with a P/E ratio of 30 and a price-to-book value of 1.19. Compared to peers, it shows a more favorable profile, despite recent stock price fluctuations and a year-to-date return down 9.40%.
Ultralife Corp. Experiences Revision in Its Stock Evaluation Amidst Competitive Landscape
Ultralife Corp., a microcap in the Electronics & Appliances sector, has adjusted its valuation, reporting a P/E ratio of 30 and a price-to-book value of 1.19. With a return on capital employed of 5.10% and return on equity of 3.95%, the company maintains a stable position compared to its peers.
Is Ultralife Corp. overvalued or undervalued?
As of October 24, 2025, Ultralife Corp. is considered undervalued with a P/E ratio of 30 compared to a peer average of 45.18, and despite a negative return of -19.00% over the past year, it has recently outperformed the S&P 500, indicating a potential turnaround and an attractive valuation outlook.
Is Ultralife Corp. overvalued or undervalued?
As of October 17, 2025, Ultralife Corp. is considered overvalued with a P/E ratio of 30 and has underperformed the S&P 500, showing year-to-date and one-year returns of -13.56% and -30.08%, respectively.
Ultralife Corp. Experiences Valuation Adjustment Amidst Challenging Market Conditions
Ultralife Corp., a microcap in the Electronics & Appliances sector, has adjusted its valuation, with its stock price at $6.44. Over the past year, it has experienced a significant decline, underperforming compared to the S&P 500. Key financial metrics suggest a need for strategic reassessment amid varied peer performance.
Is Ultralife Corp. overvalued or undervalued?
As of October 17, 2025, Ultralife Corp. is considered overvalued with a P/E ratio of 30, disappointing performance with a year-to-date return of -13.56%, and premium valuation metrics compared to peers, indicating a shift from attractive to very expensive.
Is Ultralife Corp. overvalued or undervalued?
As of October 17, 2025, Ultralife Corp. is considered very expensive and overvalued, with a P/E ratio of 30 and underperformance against the S&P 500, indicating it trades at a premium compared to its earnings and asset value.
Is Ultralife Corp. technically bullish or bearish?
As of September 8, 2025, Ultralife Corp. exhibits a mildly bearish technical trend, with underperformance of -23.88% over the year compared to the S&P 500's 17.14%, despite a short-term gain of 2.73% against the S&P's 1.05%.
Is Ultralife Corp. overvalued or undervalued?
As of September 10, 2025, Ultralife Corp. is considered very expensive and overvalued with a P/E ratio of 30, underperforming the S&P 500 with a return of -23.88% compared to the index's 17.14%.
Is Ultralife Corp. overvalued or undervalued?
As of May 29, 2025, Ultralife Corp. is considered overvalued with a P/E ratio of 30, low ROCE and ROE, and despite a recent strong monthly return of 54.40%, it has underperformed the S&P 500 over the past year, indicating concerns about sustainability at current price levels.
Is Ultralife Corp. technically bullish or bearish?
As of May 9, 2025, Ultralife Corp. is in a mildly bearish trend, primarily influenced by daily moving averages, despite mixed signals from weekly and monthly indicators.
Who are in the management team of Ultralife Corp.?
As of March 2022, Ultralife Corp.'s management team includes Independent Chairman Mr. Bradford Whitmore, President and CEO Mr. Michael Popielec, and Independent Directors Mr. Thomas Saeli, Mr. Robert Shaw, and Mr. Ranjit Singh. The team features a combination of executive leadership and independent directors.
What does Ultralife Corp. do?
Ultralife Corp. is a micro-cap company in the Electronics & Appliances industry, specializing in power solutions and communications systems, with recent net sales of $51 million and a market cap of $174.84 million.
How big is Ultralife Corp.?
As of Jun 18, Ultralife Corp. has a market capitalization of 174.84 million, with net sales of 173.27 million and a net profit of 5.38 million over the latest four quarters. Shareholder's funds are reported at 134.00 million, and total assets amount to 220.45 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
